Scher N, Panje W R
University of Chicago, Illinois.
Hematol Oncol Clin North Am. 1991 Aug;5(4):627-34.
New methods in head and neck cancer treatment have enabled the oncologic surgeon to pursue the goals of conservation of head and neck physiologic function, reduce the morbidity and mortality associated with advanced head and neck cancers, and increase the cure rates for cancers once considered inoperable. Advances in multimodality therapy may lead in the next decade to less surgical mutilation and higher cure rates.